BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23940219)

  • 21. A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
    Kalinsky K; Lee S; Rubin KM; Lawrence DP; Iafrarte AJ; Borger DR; Margolin KA; Leitao MM; Tarhini AA; Koon HB; Pecora AL; Jaslowski AJ; Cohen GI; Kuzel TM; Lao CD; Kirkwood JM
    Cancer; 2017 Jul; 123(14):2688-2697. PubMed ID: 28334439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy.
    Barbour AP; Tang YH; Armour N; Dutton-Regester K; Krause L; Loffler KA; Lambie D; Burmeister B; Thomas J; Smithers BM; Hayward NK
    Eur J Cancer; 2014 Oct; 50(15):2668-76. PubMed ID: 25070294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The surgical treatment of a melanoma patient with macroscopic metastasis in peri and retrocaval lymph nodes and with a positive sentinel lymph node in the groin.
    Giudice G; Robusto F; Nacchiero E
    Ann Ital Chir; 2016 Feb; 87(ePub):. PubMed ID: 26903177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KIT gene mutations and copy number in melanoma subtypes.
    Beadling C; Jacobson-Dunlop E; Hodi FS; Le C; Warrick A; Patterson J; Town A; Harlow A; Cruz F; Azar S; Rubin BP; Muller S; West R; Heinrich MC; Corless CL
    Clin Cancer Res; 2008 Nov; 14(21):6821-8. PubMed ID: 18980976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
    Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
    Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological and molecular study of penile melanoma.
    Oxley JD; Corbishley C; Down L; Watkin N; Dickerson D; Wong NA
    J Clin Pathol; 2012 Mar; 65(3):228-31. PubMed ID: 22011445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
    Siroy AE; Aung PP; Torres-Cabala CA; Tetzlaff MT; Nagarajan P; Milton DR; Curry JL; Ivan D; Prieto VG
    Hum Pathol; 2017 Jan; 59():48-54. PubMed ID: 27666765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
    Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
    Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.
    Hilari JM; Mangas C; Xi L; Paradelo C; Ferrándiz C; Hughes SJ; Yueh C; Altomare I; Gooding WE; Godfrey TE
    Ann Surg Oncol; 2009 Jan; 16(1):177-85. PubMed ID: 18982394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratumor Heterogeneity of KIT Gene Mutations in Acral Lentiginous Melanoma.
    Comodo-Navarro AN; Fernandes M; Barcelos D; Carapeto FCL; Guimarães DP; de Sousa Moraes L; Cerutti J; Iwamura ESM; Landman G
    Am J Dermatopathol; 2020 Apr; 42(4):265-271. PubMed ID: 31393283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers of Targeted Therapy and Immuno-Oncology in Cancers Metastatic to the Breast.
    Vranic S; Senarathne W; Stafford P; Poorman K; Pockaj BA; Gatalica Z
    Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):661-668. PubMed ID: 31517642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy.
    Li LX; Scolyer RA; Ka VS; McKinnon JG; Shaw HM; McCarthy SW; Thompson JF
    Am J Surg Pathol; 2003 Sep; 27(9):1197-202. PubMed ID: 12960803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous clear cell sarcoma: report of three cases of a potentially underestimated mimicker of spindle cell melanoma.
    Falconieri G; Bacchi CE; Luzar B
    Am J Dermatopathol; 2012 Aug; 34(6):619-25. PubMed ID: 22421295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of preoperative lymphoscintigraphy in surgery planning for sentinel lymph node biopsy in malignant melanoma.
    Vucetić B; Andreja Rogan S; Balenović A; Ivkić M; Situm M; Hudorović N; Kusić Z
    Wien Klin Wochenschr; 2006 May; 118(9-10):286-93. PubMed ID: 16810487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tumor biology of melanoma nodal metastases.
    Miliotes G; Albertini J; Berman C; Heller R; Messina J; Glass F; Cruse W; Rapaport D; Puleo C; Fenske N; Petsoglou C; Deconti R; Lyman G; Reintgen D
    Am Surg; 1996 Jan; 62(1):81-8. PubMed ID: 8540654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level.
    Sakaizawa K; Goto Y; Kiniwa Y; Uchiyama A; Harada K; Shimada S; Saida T; Ferrone S; Takata M; Uhara H; Okuyama R
    Br J Cancer; 2012 Feb; 106(5):939-46. PubMed ID: 22281663
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Ponti G; Manfredini M; Greco S; Pellacani G; Depenni R; Tomasi A; Maccaferri M; Cascinu S
    Anticancer Res; 2017 Dec; 37(12):7043-7048. PubMed ID: 29187493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.
    Ekedahl H; Cirenajwis H; Harbst K; Carneiro A; Nielsen K; Olsson H; Lundgren L; Ingvar C; Jönsson G
    Br J Dermatol; 2013 Nov; 169(5):1049-55. PubMed ID: 23855428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.
    Schaefer T; Satzger I; Gutzmer R
    Medicine (Baltimore); 2017 Jan; 96(1):e5753. PubMed ID: 28072717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ Spectrum of oncogene mutations is different in melanoma subtypes].
    Mazurenko NN; Tsyganova IV; Lushnikova AA; Ponkratova DA; Anurova OA; Cheremushkin EA; Mikhailova IN; Demidov LV
    Mol Biol (Mosk); 2015; 49(6):1022-9. PubMed ID: 26710785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.